| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Nicotinamide | Breast Cancer | 2 | PM | 35278276 | 📋 | Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent |
| Nicotinamide | Breast Cancer | 1 | PM | 32732875 | 📋 | Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer |
| Nicotinamide | Cancer | 2 | PM | 35053490 | 📋 | Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells |
| Nicotinamide | Cancer | 1 | PM | 32245130 | 📋 | The Role of Nicotinamide in Cancer Chemoprevention and Therapy |
| Nicotinamide | Cisplatin Toxicity | 1 | PM | 33722665 | 📋 | NAM protects against cisplatin-induced acute kidney injury by suppressing the PARP1/p53 pathway |
| Nicotinamide | Liver Cancer | 1 | PM | 32894639 | 📋 | Modulation of antioxidant enzymes, SIRT1 and NF-κB by resveratrol and nicotinamide in alcohol-aflatoxin B1-induced hepatocellular carcinoma |
| Nicotinamide | Lung Cancer | 1 | PM | 38593249 | 📋 | Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial |
| Nicotinamide | Melanoma | 2 | PM | 35396736 | 📋 | Cutaneous immune-related adverse events and photodamaged skin in metastatic melanoma patients: Could the use of nicotinamide be useful? |
| Nicotinamide | Melanoma | 1 | PM | 33028392 | 📋 | Nicotinamide inhibits melanoma in vitro and in vivo |
| Nicotinamide | Non-Hodgkins Lymphoma | 1 | PM | 37467318 | 📋 | Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma |
| Nicotinamide | Pancreatic Cancer | 1 | PM | 33154149 | 📋 | Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice |
| Nicotinamide | Skin Cancer | 14 | PM | 38599196 | 📋 | Efficacy of combinational treatment versus nicotinamide monotherapy in the prevention of ultraviolet radiation-induced skin cancer |
| Nicotinamide | Skin Cancer | 11 | PM | 37791183 | 📋 | Patient Perception of Skin Cancer Reduction by Nicotinamide Correlates With Use |
| Nicotinamide | Skin Cancer | 10 | PM | 35347291 | 📋 | Oral nicotinamide for non-melanoma skin cancers: A review |
| Nicotinamide | Skin Cancer | 9 | PM | 35170567 | 📋 | Nicotinamide and Nonmelanoma Skin Cancers |
| Nicotinamide | Skin Cancer | 8 | PM | 35134311 | 📋 | Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis |
| Nicotinamide | Skin Cancer | 7 | PM | 34836359 | 📋 | Creatine and Nicotinamide Prevent Oxidant-Induced Senescence in Human Fibroblasts |
| Nicotinamide | Skin Cancer | 6 | PM | 33625146 | 📋 | Nicotinamide for Keratinocyte Carcinoma Chemoprevention: A Nationwide Survey of Mohs Surgeons |
| Nicotinamide | Skin Cancer | 5 | PM | 33595161 | 📋 | Oral nicotinamide: the role in skin cancer chemoprevention |
| Nicotinamide | Skin Cancer | 1 | PM | 32383227 | 📋 | Potential Mechanisms of Cancer Prevention by Nicotinamide |
| Nicotinamide | Skin Cancer | 3 | PM | 28681504 | 📋 | Melanoma and Nonmelanoma Skin Cancer Chemoprevention: A Role for Nicotinamide? |
| Nicotinamide | Skin Cancer | 4 | PM | 28321860 | 📋 | Nicotinamide for Skin Cancer Chemoprevention |
| Nicotinamide | Skin Cancer | 13 | PM | 26655363 | 📋 | Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs |
| Nicotinamide | Skin Cancer | 2 | PM | 26488693 | 📋 | A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention |
| Nicotinamide | Skin Cancer | 12 | PM | 25478867 | 📋 | Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events |
